COP — CompuGroup Medical SE & Co KgaA Cashflow Statement
0.000.00%
Last trade - 00:00
- €1.53bn
- €2.22bn
- €1.19bn
- 70
- 44
- 18
- 38
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 66.2 | 73.4 | 69 | 74.1 | 46.9 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | -5.13 | 6.64 | -14.2 | 1.41 | 41.2 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -24.1 | -12.1 | 4.38 | -43.2 | -9.09 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 110 | 150 | 165 | 145 | 180 |
Capital Expenditures | -43.7 | -55.7 | -71.4 | -76.4 | -67.9 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -95.7 | -401 | -92.5 | -69 | -56.5 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Purchase of Investments | |||||
Sale of Intangible Assets | |||||
Cash from Investing Activities | -139 | -457 | -164 | -145 | -124 |
Financing Cash Flow Items | -2.76 | -0.562 | -0.179 | -0.192 | -4.54 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 49.7 | 338 | 30.2 | -16.4 | -80.7 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 21 | 29.6 | 31.4 | -16.8 | -26.1 |